Innoviva, Inc. INVA Giapreza — Royalty Expense
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Innoviva, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RoyaltyExpense.
The source filing: Innoviva, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:26 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335235
Pursuant to the George Washington University License (the “GW License”), GW exclusively licensed to La Jolla certain intellectual property rights relating to GIAPREZA®, including the exclusive rights to certain issued patents and patent applications covering GIAPREZA®. Under the GW License, we are obligated to use commercially reasonable efforts to develop, commercialize, market and sell GIAPREZA®. We are obligated to pay a 6% royalty on net sales of GIAPREZA® and 15% on payments received from sublicensees. The obligation to pay royalties under the GW License extends through the last-to-expire patent covering GIAPREZA®. Royalty expense incurred under the GW License for the three and six months ended June 30, 2026 were $1.4 million and $2.7 million, respectively, and $1.1 million and $2.2 million for the three and six months ended June 30, 2025, respectively.
Item 1. Financial Statements
FAQ
- What is Innoviva, Inc.'s giapreza — royalty expense?
- Innoviva, Inc. (INVA) reported giapreza — royalty expense of $1.4M in Q2 2026.
- How has Innoviva, Inc.'s giapreza — royalty expense changed year-over-year?
- Innoviva, Inc.'s giapreza — royalty expense increased by 27.3% year-over-year, from $1.1M to $1.4M.
- What is the long-term trend for Innoviva, Inc.'s giapreza — royalty expense?
- Over 2 years (2023 to 2025), Innoviva, Inc.'s giapreza — royalty expense has grown at a 34.2% compound annual growth rate (CAGR), from $2.5M to $4.5M.
- What does giapreza — royalty expense mean?
- This represents the total monetary cost incurred during a reporting period for royalty obligations related to the commercialization of a specific product. It is a key operating expense that highlights the ongoing financial commitment required to maintain rights to the underlying technology or intellectual property.
Ask your AI about Innoviva, Inc.'s giapreza — royalty expense.
Connect your AI assistant and compare segments, right in your chat.
